DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pardoprunox is an investigational drug.
There have been 6 clinical trials for Pardoprunox. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2006.
The most common disease conditions in clinical trials are Parkinson Disease, Dyskinesias, and [disabled in preview]. The leading clinical trial sponsors are Solvay Pharmaceuticals, Abbott Products, and [disabled in preview].
Recent Clinical Trials for Pardoprunox
|A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.||Abbott Products||Phase 2|
|An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients||Solvay Pharmaceuticals||Phase 3|
|An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.||Solvay Pharmaceuticals||Phase 3|